Six paired samples from two luminal B, two Her2 enriched, and two triple-negative breast cancer (TNBC) patients were used for IHC of METTL3, METTL14, FTO, YTHDF1, and YTHDF3. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.